EVIDENCE LIBRARY
Remimazolam Trial Found Memory Recovery Could Lag Behind Return of Consciousness
A randomized breast-surgery study found earlier poster recall after flumazenil, even though patients in both groups had regained consciousness. Wakefulness and memory retention were separate endpoints.
A randomized breast-surgery study found earlier poster recall after flumazenil, even though patients in both groups had regained consciousness. Wakefulness and memory retention were separate endpoints.
The comparison
Nobukuni and colleagues studied 44 patients receiving remimazolam and remifentanil anesthesia. After recovery of consciousness, 22 received flumazenil and 22 did not. Memory assessment involved showing an illustration and testing later recall.
At one hour, 95.5% in the flumazenil group remembered the poster compared with 40.9% without flumazenil. All participants could recall it by two hours. This result concerned the studied memory task after anesthesia, not every aspect of cognitive recovery.
Limits that matter
The trial was single-center and open-label, with only female, relatively younger surgical patients. The assessors’ role and patient awareness of testing reduced some concerns but did not make the trial double-blind. Re-sedation was not assessed.
The reported effect-site concentrations were model calculations. They should not be represented as directly measured brain concentrations or a universally applicable threshold for reliable recall.
Practical meaning
A patient’s response to speech does not automatically demonstrate that information given then will be retained. When evaluating postoperative conversations, identify the timing of anesthesia cessation, reversal, alertness, and the actual memory task. The study does not retrospectively establish whether a specific patient understood or remembered a particular discussion.
Source
Original analysis of the supplied paper: Effect of flumazenil on recovery of memory following recovery of consciousness from general anesthes. Paper identifier: PMC12540950.